Zhang HQ / Ghent University Hospital / VIB-Ghent University / Ghent University / / /
IndustryTerm
glycosylation end products / cancer therapy / e-pub / Cancer Treatment / re-challenge site / in vivo imaging / glycation end products / treatment of human prostate cancer / /
MedicalCondition
sterile inflammation / Cancer Treatment HMGB1 / ovarian cancer / JE / metastasis HMGB1 / colorectal cancer / prophylactic tumor / metastasis / fewer tumors / Human tumor / cisplatin-induced cancer / e.g. cancer / autologous tumor / viable cancer / J Cancer / doxorubicin-induced acute inflammation / colon cancer / Cancer Facts Immunogenic cell death / experimental cancer / colitis-associated cancer / squamous cell carcinomas / prostate cancer / indolent B-cell lymphoma patients / breast cancer / also primary tumor / human acute myeloid leukemia / brain tumor / brain tumors / murine colitis / sepsis / autoimmune diseases / chemotherapy-induced cancer / cancers / leukemia / tumor / cancer / tumors / Disease / mouse tumors / CT26 cancer / pertussis / hepatocellular carcinoma / live CT26 cancer / tumour / live cancer / doxorubicin-induced tumor / acute lymphoblastic leukemia / spontaneous mammary tumors / tumor necrosis / invasive carcinoma / lung cancer / human prostate cancer / same cancer / primary lymphoma cells / tumor metastasis / intrinsic tumor / immunogenic cancer / infection / spontaneous mammary murine tumor / inflammation / Different cancer / metastases / heat shock / acute myeloid leukemia / e.g. secondary necrosis / anemia / injuries / /
Cell Death Unit / Ghent University / Flemish Government / Ghent University Hospital / Department for Molecular Biomedical Research / VIB-Ghent University / 2Molecular Signalling and Cell Death Unit / Fund for Scientific Research Flanders / /
Person
Van Duyn / Donato R. Amphoterin / Virgilio F. Increased / Paula Vieira / / /